Mercer University, Nanotechnology Laboratory, College of Pharmacy and Health Sciences, Atlanta, GA 30341, USA.
Drug Dev Ind Pharm. 2013 Feb;39(2):164-75. doi: 10.3109/03639045.2012.664148. Epub 2012 May 17.
Oral delivery of proteins has been a challenging as well as rapidly developing field.
To implement mixture design of experiment to develop enteric-coated microparticles containing bovine serum albumin.
Microparticles were prepared using Buchi Spray Dryer 191. Simplex lattice mixture design computed using JMP software was implemented to compare the gastric protection rendered by Eudragit FS30D, Eudragit L100-55, and Eudragit S100 in microparticulate form. Further, an extreme vertices mixture design was used to incorporate hydroxypropyl methylcellulose (HPMC) Chitosan in the formulation to delay the release. Microparticle recovery yield and protein content in microparticles were evaluated.
The design was statistically significant with Eudragit S100 resulting in protein release of < 5% in acidic buffer. The selected optimal formulation had 70% of Eudragit S, 25% HPMC, and 5% Chitosan. The release profiles of protein from Eudragit S alone and along with HPMC were compared. About 25% decrease in the amount of protein release was observed 6 h post exposure of microparticle to buffer of pH 6.8. The microparticle recovery yield reduced from 77.99% to 71.56% which is due to addition of HPMC into the formulation matrix.
Although all three Eudragit polymers can be used for enteric coating, in the microparticulate form Eudragit S resulted in higher gastric protection. Also use of HPMC along with Eudragit S resulted in further sustained release.
口服递送蛋白质一直是一个具有挑战性且快速发展的领域。
实施实验混合物设计,以开发含有牛血清白蛋白的肠溶微球。
使用 Buchi 喷雾干燥器 191 制备微球。使用 JMP 软件计算 Simplex 格子混合物设计,以比较 Eudragit FS30D、Eudragit L100-55 和 Eudragit S100 在微球形式下提供的胃保护作用。此外,使用极端顶点混合物设计将羟丙基甲基纤维素(HPMC)壳聚糖纳入配方中以延迟释放。评估微球回收产率和微球中的蛋白质含量。
该设计具有统计学意义,Eudragit S100 导致酸性缓冲液中蛋白质释放<5%。选择的最佳配方含有 70%的 Eudragit S、25%的 HPMC 和 5%的壳聚糖。比较了 Eudragit S 单独和与 HPMC 一起从微球中释放蛋白质的释放曲线。暴露于 pH 6.8 的缓冲液 6 小时后,观察到蛋白质释放量减少了约 25%。由于在制剂基质中添加了 HPMC,微球回收产率从 77.99%降低到 71.56%。
尽管三种 Eudragit 聚合物均可用于肠包衣,但在微球形式下,Eudragit S 可提供更高的胃保护作用。此外,与 Eudragit S 一起使用 HPMC 可进一步实现持续释放。